A Study of Liposomal Doxorubicin+Docetaxel+Trastuzumab+Metformin in Operable and Locally Advanced HER2 Positive Breast Cancer
Clinical trial NCT02488564 · COMPLETED
Trial details
- NCT number
- NCT02488564
- Sponsor
- Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-17
- Primary completion
- 2018-10-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.